A two-part study of gastroenterologists (GEs) was conducted. One component was the analysis of 1987 Part B Medicare Annual Data to assess volume of services and patterns of reimbursement to gastroenterologists. This study demonstrated that two-thirds of services billed by GEs are medical visits, whereas two-thirds of GEs' income is derived from endoscopies. Five endoscopies account for 50% of GEs' allowed charges. Correcting for case-mix and geographic location, GEs' charges for endoscopies are still 10% higher than other physicians performing the same procedures. The second component of the study was a survey of 379 members of three major gastroenterological associations. Demographic and practice characteristics are reported and compared, when possible, with other physician specialties. Respondents estimated they spent 52 h/wk in inpatient and outpatient activities, of which 17.5 h were spent performing endoscopies. Fewer than 50% of respondents billed for 31.4 h of professional activity each week. Medicare patients comprise 38.2% of their patients. Most physicians did not balance-bill, or balance-billed Medicare patients only when they were able to pay. Malpractice premiums have risen from $6,511 to $9,540 during the past 3 yr. Over 95% of respondents were able to correctly identify those conditions requiring upper gastrointestinal (UGI) endoscopy and colonoscopy.
Download full-text PDF |
Source |
---|
J Clin Med
December 2024
Institute of Precision Diagnostics & Translational Medicine, University Hospital of Coventry and Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, UK.
Colon capsule endoscopy (CCE) is a non-invasive method for visualising the colon, but its clinical adoption has been slow. Although the COVID-19 pandemic reignited interest in CCE, its role in conventional gastrointestinal investigations remains unclear, leading to varied practices across Europe. This highlights the need for a comprehensive understanding of diverse approaches to CCE in clinical practice.
View Article and Find Full Text PDFCrohns Colitis 360
January 2025
GI Medical, Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.
Background: Crohn's perianal fistulas (CPF) are difficult to manage and often require multiple interventions. This study aimed to assess the preferences of patients and healthcare professionals (HCPs) for attributes of CPF-related procedures/surgeries to better inform CPF management.
Methods: This US cross-sectional, observational study was conducted via a web-enabled questionnaire (October 2021-January 2022) among patients aged 21-89 years with a self-reported physician diagnosis of CPF (with or without CPF-related surgery experience) and HCPs (gastroenterologists and colorectal surgeons who managed ≥3 patients with CPF in the past 12 months).
Dig Dis Sci
January 2025
Department of Medicine and Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Despite growing numbers of women entering medicine, women remain underrepresented in gastroenterology (GI) in the United States and globally, and barriers to equity persist. Prior studies describing gender makeup and ongoing challenges for women in GI have largely reflected the physician experience in the United States (US). In this study by Venezia et al.
View Article and Find Full Text PDFArq Gastroenterol
January 2025
Universidade de Campinas, Departamento de Gastroenterologia, Campinas, SP, Brasil.
Background: Microscopic colitis (MC) is a chronic inflammatory condition of the colon, primarily characterized by watery diarrhea, with normal or near-normal endoscopic findings. It encompasses two main subtypes: lymphocytic colitis and collagenous colitis.
Objective: This position paper from the Brazilian Federation of Gastroenterology aims to review current evidence on the diagnosis and management of MC in Brazil, emphasizing the need for standardization across the country's healthcare systems.
Surg Endosc
January 2025
Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, 69437, Lyon, France.
Background: Accurate endoscopic characterization of colorectal lesions is essential to predict histology and select the best treatment strategy but remains very difficult. Instead of the recommended endoscopic characterization, many gastroenterologists routinely perform biopsies of the lesion to propose endoscopic resection with or without R0 intent. The aim of this study was to determine which of endoscopic characterization or biopsies, either targeted (TB) or non-targeted (NTB), is the most effective to determine the best treatment strategy for colorectal neoplasia > 2 cm.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!